Bijie Biotech

Bijie Biotech is a Suzhou-based biotechnology company specializing in the isolation, detection, and clinical application of exosomes. The company has developed the proprietary Exo-X platform, which enables high-purity and high-efficiency enrichment of exosomes from liquid biopsies. Their primary focus is on developing non-invasive liquid biopsy diagnostics for early cancer detection and monitoring treatment response. Additionally, Bijie Biotech is exploring exosome-based therapeutic delivery systems and targeted therapies. The company's portfolio includes diagnostic kits for various solid tumors and collaborations with clinical institutions to validate exosome-derived biomarkers. Bijie Biotech aims to bridge the gap between basic exosome research and clinical practice through its integrated technology platform.